ENTRABODY
Dead / Cancelled — Cancelled — Section 8 (as of 26 Apr 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87150020
- Registration number
- 5308014
- Mark type
- Stylized text
- Filed
- 24 Aug 2016
- Published for opposition
- 10 Jan 2017
- Registered
- 10 Oct 2017
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer
Owner
- Landing Biotech, Inc., Newton, MA, US
- Landing Biotech, Inc., Newton, MA, US
- Landing Biotech, Inc., Newton, MA, US
Prosecution history
- 26 Apr 2024 — CANCELLED SEC. 8 (6-YR)
- 10 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 08 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Aug 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Jul 2017 — USE AMENDMENT FILED
- 11 Aug 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
- 08 Mar 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jan 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jan 2017 — PUBLISHED FOR OPPOSITION
- 21 Dec 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Dec 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Dec 2016 — ASSIGNED TO EXAMINER